Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Schmidt-Erfurth: Same-day administration of verteporfin and ranibizumab 0.5 mg in patients.... (0.08 sec) 

Same-day administration of verteporfin and ranibizumab 0.5 mg in patients with choroidal …

- prsjournal.com
U Schmidt-Erfurth, S Wolf - British Journal of Ophthalmology, 2008 - bjo.bmj.com
Results: No severe vision loss due to ocular inflammation or uveitis occurred.
One patient had moderate vision loss (BCVA loss ⩾15 letters). Three patients
had mild/moderate uveitis. Two serious ocular adverse events occurred ...
Cited by 2 - Related articles - All 6 versions

Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety …

- nih.gov
LJ Singerman, H Masonson, M Patel, AP … - British Medical Journal, 2008 - bjo.bmj.com
Methods: Two concurrent, prospective, multicentre, double-masked studies
randomised subjects with all angiographic lesion compositions of NV-AMD to
receive intravitreous pegaptanib sodium (0.3, 1 and 3 mg) or sham ...
Cited by 4 - Related articles - All 9 versions

Foveal RPE autofluorescence as a prognostic factor for anti-VEGF therapy in exudative AMD


B Heimes, A Lommatzsch, M Zeimer, M … - Graefe's Archive for Clinical and Experimental …, 2008 - Springer
Abstract Background Autofluorescence (AF) of the retinal pigment epithelium
(RPE) are thought to reflect metabolic activity of the RPE cells, which in turn
is largely driven by photoreceptor outer segment renewal. In exudative AMD, ...
Cited by 4 - Related articles - All 2 versions

Endophthalmitisrate mit und ohne topische postoperative Antibiotikagabe nach intravitrealer …


CH Meyer, S Mennel, N Eter - Der Ophthalmologe, 2007 - Springer
Die postoperative Endophthalmitis wird als eine der schwerwiegendsten Kompli-
kationen nach intravitrealen Injektionen gewertet. Die Endophthalmitisrate nach
intravitrealen Injektionen von Triamci- nolon (IVT) liegt bei 1:1000 (0,1%) ...
Cited by 5 - Related articles - BL Direct - All 3 versions

[CITATION] Off label use-Arzneimittelrechtliche, haftungsrechtliche, berufsrechtliche und …


R Francke, D Hart - Die Sozialgerichtsbarkeit, 2003
Cited by 7 - Related articles

[CITATION] Fachinformation Lucentis®(Stand August 2008)


NP GmbH - Rote Liste GmbH, 2008
Cited by 2 - Related articles

[CITATION] Rechtsfortbildung dank Lucentis


C Dierks, G Nitz - Gesellschaftspolitische Kommentare, 2008
Cited by 2 - Related articles

Retinale Pigmentepithelrisse nach intravitrealem Bevacizumab bei AMD


D Kook, A Wolf, AS Neubauer, C Haritoglou, … - Der Ophthalmologe, 2008 - Springer
Jüngst wurde die altersbedingte Makula- degeneration (AMD) als eine
„sozioöko- nomische Zeitbombe“ in der alternden Gesellschaft beschrieben
[29]. Neue me- dikamentöseBehandlungsansätzesindje- doch in der Lage, die ...
Cited by 2 - Related articles - BL Direct

[CITATION] Investigator Notification for ranibizumab: Lucentis Meta-Analysis


NSO Novartis, CH Basel, 2008
Cited by 2 - Related articles

[CITATION] Arzthaftung und off label use. Information, Standard und Zulassung


D Hart - Medizinrecht heute: Erfahrungen, Analysen, …, 2008
Cited by 2 - Related articles


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google